Table 1 Characteristics of included studies on CVD risk calculators
Authors/ year | CVD calculators | Study design | Level of evidence |
|---|---|---|---|
Mendis et al. / 2007 [19] | WHO/ISH risk charts | A Hypothetical cohort for different 14 sub-regions | Level II prognostic study |
Hippisley-Cox et al. / 2007 [10] | Framingham risk score QRISK1® ASSIGN | A Prospective open cohort study | Level I prognostic study |
Beswick et al. / 2008 [24] | A total of 70 risk scoring methods | Series of systematic reviews | Level I prognostic study |
Hippisley-Cox et al. / 2008 [18] | Framingham risk score QRISK1® QRISK2® | A Prospective open cohort study | Level I prognostic study |
Collins et al. / 2009 [25] | Framingham risk score QRISK1® | A Prospective open cohort study | Level I prognostic study |
Collins et al. / 2010 [17] | Framingham risk score QRISK1® & QRISK2® | A Prospective open cohort study | Level I prognostic study |
Mendis et al. / 2011 [26] | WHO/ISH risk charts | A Cross-sectional population-based survey | Level IV prognostic study |
Siontis et al. / 2012 [27] | Framingham risk score ASSIGN SCORE PROCAM Reynolds risk score QRISK1® & QRISK2® | A Systematic review of comparative predictive model studies | Level I prognostic study |
Kariuki et al. / 2013 [28]Â | Framingham non-laboratory Gaziano non-laboratory WHO/ISH non-laboratory Swedish Consultation-based UK General Practice model | A Systematic review of non-laboratory-based CVD algorithms | Level I prognostic study |
Otgontuya et al. / 2013 [29] | WHO/ISH risk charts | A Retrospective cohort study in 3 Asian countries | Level II prognostic study |
Bansal et al. / 2014 [30] | JBS3 CVD risk calculator ACC/AHA ASCVD) Risk Framingham risk score WHO/ISH risk charts | A Cross-sectional study | Level IV prognostic study |
Selvarajah et al. / 2014 [31] | Framingham risk score SCORE-high and -low WHO/ISH risk charts | A Retrospective cohort study | Level II prognostic study |
Ofori et al. / 2017 [32] | ACC/AHA ASCVD) Risk Framingham risk score WHO/ISH risk charts | A Cross-sectional study | Level IV prognostic study |
Bonner et al. / 2018 [33]Â | 73 unique CVD risk calculators | A Systematic review to measure the validity, understandability, and actionability of online CVD risk calculators | Level I prognostic study |
Kaptoge et al. / 2019 [34] | 2019 WHO risk charts | A Retrospective cohort study from 21 global regions | Level II prognostic study |
Hasabullah et al. / 2020 [21] | Framingham risk score SCORE ACC/AHA ASCVD) Risk QRISK® | A Cross-sectional study | Level IV prognostic study |
Hosein et al. / 2020 [35] | Framingham risk score ASSIGN QRISK2® | A Cross-sectional study | Level IV prognostic study |